Glucogallin Attenuates the LPS-Induced Signaling in Macrophages and Protects Mice against Sepsis
The anti-oxidant and anti-inflammatory effect of beta-glucogallin (BGG), a plant-derived natural product, was evaluated in both in vitro and in vivo studies. For the in vitro study, the ability of BGG pre-treatment to quench LPS-induced effects compared to LPS alone in macrophages was investigated. It was found that BGG pre-treatment showed a significant decrease in ROS, NO, superoxide, and pro-inflammatory cytokines (TNF-alpha, IL-4, IL-17, IL-1β, and IL-6) and increased reduced glutathione coupled with the restoration of mitochondrial membrane potential. Gene profiling and further validation by qPCR showed that BGG pre-treatment downregulated the LPS-induced expression of c-Fos, Fas, MMP-9, iNOS, COX-2, MyD88, TRIF, TRAF6, TRAM, c-JUN, and NF-κB. We observed that BGG pre-treatment reduced nuclear translocation of LPS-activated NF-κB and thus reduced the subsequent expressions of NLRP3 and IL-1β, indicating the ability of BGG to inhibit inflammasome formation. Molecular docking studies showed that BGG could bind at the active site of TLR4. Finally, in the LPS-driven sepsis mouse model, we showed that pre-treatment with BGG sustained toxic shock, as evident from their 100% survival. Our study clearly showed the therapeutic potential of BGG in toxic shock syndrome..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
International Journal of Molecular Sciences - 23(2022), 19, p 11254 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rajveer Singh [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Anti-inflammatory |
|---|
| doi: |
10.3390/ijms231911254 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ021303517 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ021303517 | ||
| 003 | DE-627 | ||
| 005 | 20240414184857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms231911254 |2 doi | |
| 035 | |a (DE-627)DOAJ021303517 | ||
| 035 | |a (DE-599)DOAJ3cbcdb6ed9f040e38ffda5e94ad881bb | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a QH301-705.5 | |
| 050 | 0 | |a QD1-999 | |
| 100 | 0 | |a Rajveer Singh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Glucogallin Attenuates the LPS-Induced Signaling in Macrophages and Protects Mice against Sepsis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The anti-oxidant and anti-inflammatory effect of beta-glucogallin (BGG), a plant-derived natural product, was evaluated in both in vitro and in vivo studies. For the in vitro study, the ability of BGG pre-treatment to quench LPS-induced effects compared to LPS alone in macrophages was investigated. It was found that BGG pre-treatment showed a significant decrease in ROS, NO, superoxide, and pro-inflammatory cytokines (TNF-alpha, IL-4, IL-17, IL-1β, and IL-6) and increased reduced glutathione coupled with the restoration of mitochondrial membrane potential. Gene profiling and further validation by qPCR showed that BGG pre-treatment downregulated the LPS-induced expression of c-Fos, Fas, MMP-9, iNOS, COX-2, MyD88, TRIF, TRAF6, TRAM, c-JUN, and NF-κB. We observed that BGG pre-treatment reduced nuclear translocation of LPS-activated NF-κB and thus reduced the subsequent expressions of NLRP3 and IL-1β, indicating the ability of BGG to inhibit inflammasome formation. Molecular docking studies showed that BGG could bind at the active site of TLR4. Finally, in the LPS-driven sepsis mouse model, we showed that pre-treatment with BGG sustained toxic shock, as evident from their 100% survival. Our study clearly showed the therapeutic potential of BGG in toxic shock syndrome. | ||
| 650 | 4 | |a beta-glucogallin | |
| 650 | 4 | |a lipopolysaccharide | |
| 650 | 4 | |a macrophages | |
| 650 | 4 | |a gene expression profiling | |
| 650 | 4 | |a anti-inflammatory | |
| 650 | 4 | |a sepsis | |
| 653 | 0 | |a Biology (General) | |
| 653 | 0 | |a Chemistry | |
| 700 | 0 | |a Shivani Chandel |e verfasserin |4 aut | |
| 700 | 0 | |a Arijit Ghosh |e verfasserin |4 aut | |
| 700 | 0 | |a Tushar Matta |e verfasserin |4 aut | |
| 700 | 0 | |a Anupam Gautam |e verfasserin |4 aut | |
| 700 | 0 | |a Arka Bhattacharya |e verfasserin |4 aut | |
| 700 | 0 | |a Srivalliputturu Sarath Babu |e verfasserin |4 aut | |
| 700 | 0 | |a Soumi Sukla |e verfasserin |4 aut | |
| 700 | 0 | |a Debasish Nag |e verfasserin |4 aut | |
| 700 | 0 | |a Velayutham Ravichandiran |e verfasserin |4 aut | |
| 700 | 0 | |a Syamal Roy |e verfasserin |4 aut | |
| 700 | 0 | |a Dipanjan Ghosh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t International Journal of Molecular Sciences |d MDPI AG, 2003 |g 23(2022), 19, p 11254 |w (DE-627)DOAJ00014584X |x 14220067 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g number:19, p 11254 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/ijms231911254 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/3cbcdb6ed9f040e38ffda5e94ad881bb |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/1422-0067/23/19/11254 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1661-6596 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1422-0067 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2022 |e 19, p 11254 | ||